A20 inhibits NF-κB activation by dual ubiquitin-editing functions

Deregulation of the transcription factor NF-κB can mediate several inflammatory diseases in addition to cancer. Therefore, several proteins, including the zinc finger protein A20, tightly control its activation. Recently, the underlying mechanism by which A20 downregulates NF-κB activation in response to the pro-inflammatory cytokine tumor necrosis factor (TNF) has been described. A20 was shown to exert two opposing activities: sequential de-ubiquitination and ubiquitination of the TNF receptor-interacting protein (RIP), thereby targeting RIP to proteasomal degradation.

[1]  R. Contreras,et al.  The Zinc Finger Protein A20 Inhibits TNF-induced NF-κB–dependent Gene Expression by Interfering with an RIP- or TRAF2-mediated Transactivation Signal and Directly Binds to a Novel NF-κB–inhibiting Protein ABIN , 1999, The Journal of cell biology.

[2]  G. Natoli,et al.  Nuclear Factor kB-independent Cytoprotective Pathways Originating at Tumor Necrosis Factor Receptor-associated Factor 2* , 1998, The Journal of Biological Chemistry.

[3]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[4]  G Cantarella,et al.  Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.

[5]  Zhijian J. Chen,et al.  The novel functions of ubiquitination in signaling. , 2004, Current opinion in cell biology.

[6]  G. Courtois,et al.  The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.

[7]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[8]  A. Beaudet,et al.  Human disorders of ubiquitination and proteasomal degradation. , 2004, Current opinion in pediatrics.

[9]  A. Ma,et al.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.

[10]  S. Wing.  Deubiquitinating enzymes--the importance of driving in reverse along the ubiquitin-proteasome pathway. , 2003, The international journal of biochemistry & cell biology.

[11]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[12]  R. Beyaert,et al.  A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.

[13]  R. Beyaert,et al.  The cytokine‐inducible zinc finger protein A20 inhibits IL‐1‐induced NF‐κB activation at the level of TRAF6 , 1999, FEBS letters.

[14]  H. Ploegh,et al.  Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. , 2004, The Biochemical journal.

[15]  D. Goeddel,et al.  The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Beyaert,et al.  Functional redundancy of the zinc fingers of A20 for inhibition of NF‐κB activation and protein–protein interactions , 2001, FEBS letters.

[17]  Genhong Cheng,et al.  The signaling adaptors and pathways activated by TNF superfamily. , 2003, Cytokine & growth factor reviews.

[18]  E. Koonin,et al.  A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. , 2000, Trends in biochemical sciences.

[19]  T. Blundell,et al.  A Novel Type of Deubiquitinating Enzyme* , 2003, Journal of Biological Chemistry.

[20]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[21]  M. Kelliher,et al.  The Kinase Activity of Rip1 Is Not Required for Tumor Necrosis Factor-α-induced IκB Kinase or p38 MAP Kinase Activation or for the Ubiquitination of Rip1 by Traf2* , 2004, Journal of Biological Chemistry.

[22]  J. Tschopp,et al.  Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation , 2003 .

[23]  R. Beyaert,et al.  Identification of a Novel A20-binding Inhibitor of Nuclear Factor-κB Activation Termed ABIN-2* , 2001, The Journal of Biological Chemistry.

[24]  M. Balakirev,et al.  Otubains: a new family of cysteine proteases in the ubiquitin pathway , 2003, EMBO reports.

[25]  M S Boguski,et al.  The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. , 1990, The Journal of biological chemistry.

[26]  S. Fang,et al.  Ubiquitin-proteasome system , 2004, Cellular and Molecular Life Sciences CMLS.